IMUX FY 2025 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena

IMUXImmunic, Inc.

$135M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$168,000

Operating Income

-$103M

Net Income

-$97M

EPS (Diluted)

$-0.62

Cash Flow

Operating Cash Flow

-$86M

Free Cash Flow

-$86M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$24M

Total Liabilities

$31M

Stockholders' Equity

-$7M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$168,000	$0	—
Operating Income	-$103M	-$98M	-5.3%
Net Income	-$97M	-$101M	+3.3%